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ABSTRACT 
There are studies showing the effects of long-term ovarian hormones withdrawal and post-menopause on animal behavior. Ovarian hormones 
play a critical role is modulating anxiety and depressive symptoms in female. Thus, this current study evaluated the anxiety and depression of 
long-term ovariectomy (OVX) in adult rats subjected to the light and dark chamber and forced swimming tests. In this study, we tested the 
effect of hydroalcoholic extract of Dalbergia sissoo on female anxiety and depression in long-term postsurgical bilateral ovariectomized female 
rats. 6-month old female Wistar rats were used and distributed in 5 groups; diestrus rats, ovariectomized (OVX) groups with 60 days, OVX 
treated with standard β Estradiol (0.1mg/kg/s.c), OVX treated hydroalcoholic extract of Dalbergia sissoo (200 & 400 mg/kg). All treatments 
were given for further 28 days after post-surgical period (60 days) in ovariectomized female rats. They were evaluated on the 28th day in the 
light and dark chamber and forced swim test apparatus. The treatment of the hydroalcoholic extract of Dalbergia sissoo (200 and 400 mg/kg) in 
the OVX rats shows significant increase in the time spent in the light chamber and the immobility time was significantly decrease in the 
extracted treated groups as compared to the OVX group. Anxiety-like and depressive-like behaviors were observed in rats which were 
influenced by post-menopause or ovarian hormone withdrawal. Results suggested that 28 days of treatment with hydroalcoholic extract of 
Dalbergia sissoo is able to lower the anxiety levels and depression in estrogen deficient females.  
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Depression and anxiety are among the most cited 
psychological symptoms related to the absence of ovarian 
hormones that are observed in postmenopausal women [1, 2]. 
In human, menopause causes depletion of estrogens, 
whereas in experimental animals OVX is a common method 
to deplete animals of their gonadal hormones. In females the 
absence of the ovaries induces a drastic decrease of 
circulating estrogens [1].  Women carry a greater burden of 
affective and anxiety disorders than do men, with the 
lifetime prevalence of depression in women at about 21% 
compared with 13% in men [4]. During the perimenopausal/ 
menopausal period, which occurs at approximately 45-55 
years of age, women often suffer from mood disorders such 
as depression, altered emotionality, and malaise [5, 6, 7]. 
Depressive symptoms develop during natural and surgical 
menopause, and estrogen replacement therapy has been 
used as a beneficial treatment for many years [8]. Relatively 
high levels of depression and anxiety have been reported in 
women post physiological or after surgical induction of 
menopause in comparison with premenopausal intact 
women [1, 9].  
Okada et al. (1997) demonstrated that ovariectomized rats 
showed significantly prolonged immobility as compared to 
sham-operated rats 14 days after ovariectomy [10]. 
Therefore, it is conceivable that the prolongation of 
immobility following ovariectomy might be a useful tool for 
experimentally investigating menopausal depression and for 
evaluating the efficacy of potential treatments [11].  
Studies have demonstrated that 17β-estradiol, a primary 
estrogen produced by the ovaries, decrease anxiety- related 
behavior and produce antidepressant-like effects in animal 
models. In fact, proestrus rats, which have high physiological 
17β-estradiol levels, have decreased anxiety-like behavior 
across a variety of tasks and decreased mobility time in the 
forced swim test compared to female rats in diestrus phases, 
which have lowering 17β-estradiol levels [12, 13, 14]. 
Furthermore, the administration of 17β-estradiol regimen in 
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OVX rats produces anti-anxiety and antidepressant-like 
effects compared to non-treated animals [15, 16]. Behavioral 
and neurochemical studies employ OVX rats 1-4 weeks after 
surgery as an animal model of menopause. This time frame 
is generally adopted as a consequence of lower plasma 
concentrations of estrogens and progestins in OVX 
compared to intact animals [17].  
The actions of phytoestrogens are principally established by 
interactions with ERα and ERβ, which are differentially 
distributed in the brain and other organs [18]. Diverse natural 
or synthetic compounds can be recognized by estrogen 
receptors, thus regulating most of the physiological 
processes that depend on estrogens. The activation of ERβ 
produces anxiolytic and antidepressant-like effects [19].  
Dalbergia sissoo, popularly known as shisham in India, is an 
erect deciduous tree.  D.  sissoo is widely available 
throughout the Indian subcontinent. Phytopharmacological 
evaluation program aimed at finding an effective alternative 
therapy for postmenopausal osteoporosis, we recently 
reported that several phytoestrogens, particularly methoxy 
isoflavones, were present in the crude extract made from the 
leaves of D.  sissoo and exhibited in vitro bone-forming 
activity [20].  Comprehensive investigation of D.  sissoo 
reported to contain estrogenic flavonoids and some sterols 
with estrogenic activity.  The reported results of 
phytochemical analysis indicated to the presence of 
flavonoids in Dalbergia sissoo [21]. Thus, the objective of the 
present study was to evaluate the anxiolytic and 
antidepressant effect of hydro alcoholic extract of Dalbergia 
sissoo on bilateral ovariectomized induced post-menopausal 
female rats. 
MATERIALS AND METHODS 
Collection and Identification of Plant Material: 
D. sissoo leaves were collected from the surrounding area of 
rural Pune during September 2018. The plant was identified 
and authenticated by M/s. Shamantak Enterprises, Dr. 
Gautam, Botanist, Pune, India. 
Preparation of Plant Extract: 
A weighed quantity (50g) of the air-dried powdered leaves 
of D.  sissoo was drawn and then it was extracted with 90% 
ethanol in a Soxhlet extractor. The hydroalcoholic extract 
was concentrated in a rotary flash evaporator at a 
temperature not exceeding 50˚ C to get a solid residue. 
Different concentration (200mg/kg and 400mg/kg p.o.) of 
hydroalcoholic extract of leaves of D. sissoo was given 
according to body weight of animals [22]. 
Animals: 
The study was undertaken at the AISSMS College of 
Pharmacy, Pune. The Institutional Animal Ethical Committee 
approved the protocol (CPCSEA/IAEC/PC-08/01-2K18) for 
the study. Wistar female rats (200-250g) of about 6 months 
were used. They were maintained at 25±2º C and relative 
humidity of 45 to 55% and under light dark cycle (12 h light: 
12 h dark cycle). The animals had free access to food and 
water ad libitum throughout study. All experiments were 
carried out between 9:00 – 16:00 hours.  
Surgical Procedure of bilateral Ovariectomy (OVX): 
The acclimatized rats were ovariectomized using the dorsal 
midline skin incision. The rats underwent surgical procedure 
after being anesthetized with ketamine (80 mg/kg). Rat was 
put on its ventral surface and ovariectomy was preceded by 
a single 2 cm long longitudinal skin incision on the dorsal 
midline (the hump) and the base of tail. After deep incision 
the bilateral ovaries were found, surrounded by a variable 
amount of fat. Ligation of blood vessels was necessary. Both 
ovaries were identified and then silk thread was tightly tied 
around the oviduct, including the ovarian blood vessels. The 
oviduct was cut and ovary was removed, taking good care in 
leaving the knot intact. The uterine horn was returned into 
the abdominal cavity. The muscle incision was required 
suturing with 0 size chromic absorbable catguts. The skin 
was sutured with non-absorbable silk thread. Broad 
spectrum antibiotic Neosporin antibiotic powder was used 
topically after surgery for 15 consecutive days [23].  
Animal Grouping and Treatment Protocol: 
After 1 month, ovariectomized rats were categorized into 5 
groups. Group 1 – Diestrus group, Group 2 – OVX rats, Group 
3 – Ovx treated with Estradiol benzoate (0.1 mg/kg/s.c), 
Group 4 and 5 – Ovx treated with hydroalcoholic extract of 
Dalbergia sissoo (200 and 400 mg/kg/p.o respectively). 
Treatments i.e. standard Estradiol (0.1 mg/kg/s.c), D. sissoo 
(200 & 400 mg/kg/p.o), respectively were given for a period 
of 28 days. 
Vaginal cytology:  
To evaluate the animals for anxiety and depression in the 
diestrus phase, estrous cycle phases were determined by 
vaginal lavage [24] every morning between 8:00 to 9:00 a.m. 
and female rats with at least two regular 4-day cycles were 
used.   
 
Fig 1. Vaginal cytology – Diestrus Phase 
Forced Swimming test: 
The forced swimming test by VJ Instruments, consisted of 
placing rats, individually, in Plexiglas cylinders (46 cm high, 
20 cm in diameter) containing water (24-26 ˚C, 30 cm deep), 
for two swimming sessions: an initial 15-min training 
session, which was followed, 24 h later, by a 5-min test 
session [25]. At the end of each swimming session, the animal 
was removed from the cylinder, dried with paper towels, 
placed in an individual cage to rest and recover for 15 min 
and then returned to its collective home cage. Three 
behavioral parameters were scored cumulatively in the 
second swimming session test only: (i) immobility time (i.e. 
the time spent floating in the water without struggling, 
making only those movements necessary to keep the head 
above the water), (ii) swimming time (i.e. the time spent 
making active swimming motions to move around in the 
cylinder) and (iii) climbing time (i.e. the time spent making 
active movements with its forepaws in and out of the water, 
directed specifically to the cylinder wall) [17].  
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Fig 2. Forced Swim Test Apparatus 
Light – dark box testing: 
The apparatus used for the Light/Dark Box test by VJ 
Instruments, consist of a cage divided into two chambers 
divided by a partition with a door. One chamber is brightly 
illuminated with a lamp, whereas the other chamber is dark. 
It was made of Plexiglas (20×30×30 cm light chamber and 
dark chamber each).  
 
Fig 3. Light/Dark Box Test Apparatus 
The chambers were connected by a 10×10 cm door in the 
middle of the wall separating the two chambers. Animals 
were habituated to the experimental room for at least 30 
min before the beginning of the test. After habituation, the 
animal was placed in the middle of the light chamber facing a 
side away from the door and then released. They were 
allowed to move freely between the two chambers with the 
door open for 10 min. the latency to first enter the light 
chamber, the locomotor activity in each chamber, the total 
number of transitions between chambers, and the time 
spent in each chamber can be recorded. Transitions between 
the light and dark chambers and total locomotor activity, as 
an indication of exploratory activity, were measured for 10 
min [26]. 
Statistical Analysis: 
Statistical analysis was carried out using GraphPad Instat 3. 
All of the data is shown as the mean ± standard error of the 
mean (S.E.M) and were analyzed using one-way analysis of 
variance (ANOVA). Significant differences between the 
estrous control and experimental groups were determined 
using Tukey-Kramer test all comparison test, P<0.001 was 
considered significant. 
RESULTS AND DISCUSSION 
Forced Swimming Test: 
The forced swimming test was used to evaluate behavioral 
despair. Depressive-like behavior was defined as an increase 
in the time (in seconds) spent immobile. At the 8th week of 
OVX, rats showed significant increase in immobility time and 
decrease in swimming time as compared to diestrus control 
group. Following Estradiol benzoate treated (0.1 mg/kg s.c. 
for 28 days from 4th week after OVX), rats showed a 
decreased immobility and increased swimming time on the 
28th day as compared to diestrus group and OVX group. 
There were significant differences in swimming behavior 
and swimming time was increased and immobility time was 
decreased in the D. sissoo 400 mg/kg after the 28 days of 
treatment. There was no significant interaction between the 
treatment group and diestrus group for struggling (P<0.05). 
Results are shown in Table 1. 
  
Table 1: Effect of D. sissoo in the 5 min forced swimming test apparatus in rats 
Groups Immobility (s) Swimming (s) Struggling (s)  
Diestrus Control 32±1.39 176.83±6.17 91.16±6.84 
OVX  82±3.10 115.5±9.07** 102.5±10.19 
Standard Estradiol 0.1 mg/kg/s.c 30.83±5.51 191.66±8.38 77.5±5.30 
D. sissoo 200 mg/kg p.o. 43±14.44 164.17±16.28 92.83±2.63 
D. sissoo 400 mg/kg p.o.  24.5±3.69 190.16±12.28* 85.33±9.26 
Results are expressed as mean ± SEM. (n=6) Data was analyzed by one-way analysis of variance (ANOVA) followed by Tukey-
Kramer’s test. *p<0.05, **p<0.001. 
 
Light-Dark Box Test: 
The time spent in the light box was significantly increased in 
the D. sissoo 200 and 400 mg/kg (P<0.05, P<0.001 
respectively) compared with the diestrus control group. The 
time spent by the OVX animals in the light box was less than 
that of the diestrus group and was not significant (P>0.05). 
Latency to enter dark was more significant in the D. sissoo 
400 mg/kg (P<0.001). number of crossings showed no 
significant interactions between the groups (P>0.05). 
Locomotor activity in the light box was significant in the 
standard estradiol group and also D. sissoo 400 mg/ kg 
group (P<0.001). There was significant increase in the 
locomotor activity of the OVX group in the dark box (P<0.05) 
and no significant interactions with other treatment groups 
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Table 2: Effect of D. sissoo in 10 min light/dark transition test in rats 
Groups Time in light 
box (s) 





activity in light 
box 
Locomotor 
activity in dark 
box 
Diestrus Control 35.16±7.24 12.83±1.88 25±1.39 45.83±7. 05 211.66±19.49 
OVX 25.66±3.38 5±0.51 21.5±2.77 88.5±17.96 528.66±51.59* 
Standard Estradiol 0.1 
mg/kg/s.c 
47±4.82 8.33±0.55* 27.5±2.20 125.83±16.55** 442.33±99.81 
D. sissoo 200 mg/kg 45.16±9.32* 8.16±1.07* 19.66±1.89 62±11.20 291.33±52.08 
D. sissoo 400 mg/kg 61.5±8.31** 6.5±0.76** 23.16±1.74 120.83±10.90** 294.16±27.74 
Results are expressed as mean ± SEM. (n=6) Data was analyzed by one-way analysis of variance (ANOVA) followed by Tukey-
Kramer’s test. *p<0.05, **p<0.001. 
 
Studies have shown that experimental anxiety levels can 
vary during hormonal fluctuations period in female rats [12, 
27, 28, 29]. Likewise, it has been observed that higher anxiety 
levels match with lower plasmatic concentrations of ovarian 
hormones in distinct animal models [12, 30, 31]. It should be 
noted that in menopausal women, ovarian hormones 
biosynthesis reduces gradually, whereas after surgical 
removal of ovarian glands estrogen and other steroid 
hormones reduces abruptly in the blood [32]. In this context, 
it is known that hormone therapy in perimenopause women 
promoted potential cognitive benefits, but these positive 
effects disappear when initiating the administration in late 
post menopause [33]; preclinical findings also support these 
observations [34]. Therefore, it suggests that a rapid and 
consistent reduction of gonadal circulating hormones may 
be related to decreased responsiveness to ovarian steroids, 
such as estradiol, which could contribute to synaptic 
alterations in estradiol brain targets [17]. 
Literature data have shown that in the forced swimming 
test, ovariectomized rats display significantly prolonged 
immobility time in comparison with intact or diestrus 
animals [10, 11, 35]. Chronic treatment with estradiol after 
ovariectomy significantly shortened the duration of 
immobility in a dose-dependent manner. The recovery of the 
duration of immobility after chronic treatment with estrogen 
concurs with the results of a previous study of OVX rats [10]. 
Therefore, it is conceivable that the depletion of estrogen 
correlates closely with the manifestation of depressive-like 
behavior. Although numerous clinical studies have indicated 
that estrogen plays an essential role in the manifestation of 
mood disorders in peri- and postmenopausal women [36], 
information concerning the possible role of estrogen on 
depressive-like behavioral states in laboratory animals is 
limited. In female rats, estrogen produced an 
antidepressant-like effect during forced swimming test [37, 38, 
15]. Furthermore, estrogen has been shown to modulate 
neurotransmission in the brain [39, 40] especially through 
serotonin in receptors [41]. Because it is clear that behavioral 
changes during the forced swimming test following 
ovariectomy depend upon estrogen concentrations, the 
experimental protocol that we used in this study may 
provide clues as to whether there are interactions among 
these variables [11].  
The data obtained from the Light/Dark box test is generally 
visualized by graphing the time the animal spends either in 
the dark or in the light chamber. The time spent in the light 
chamber can be easily graphed and compared. The latency to 
first enter the light chamber, the distance traveled in each 
chamber, and the total number of transitions between 
chambers can also be presented. However, since the time 
spent in the bright chamber is regarded as the most 
consistent and useful measurement in dose-effect 
pharmacological evaluations [42]. In this study, the time spent 
in light area latency to enter dark chamber and tunnel 
crossing is an index of anxiety. The Dalbergia sissoo extract 
(400 mg/kg) had significantly increased the time spent in 
light area, latency to enter dark chamber and tunnel 
crossing, similar to standard drug, suggesting that anxiolytic 
activity of D. sissoo leaves extract as compare to diestrus 
control group. 
Taken together, this information contributes to understand 
the effect of ovarian hormone withdrawal in modulating the 
anxiety and depressive behaviors in female rats. The present 
study provides evidence that the ethanolic extract of 
Dalbergia sissoo is a shown to have anxiolytic and anti-
depressant like effects in ovariectomized rats. Therefore, 
further comparative studies, including neurobiological tests, 
are needed to establish an animal model of 
psychopathological depression and anxiety. 
CONCLUSION 
The main findings of the present study can be summarized 
as follows: (a) OVX rats displayed an anxiogenic-like 
behavior compared to diestrus control group, (b) OVX 
animals showed increase in the immobility time compared 
to diestrus group, (c) Standard estradiol benzoate (0.1 
mg/kg s.c.) showed anxiolytic and antidepressant-like 
behavior after the treatment, (d) D. sissoo 400 mg/kg 
showed significant effect of anxiolytic and antidepressant-
like behavior as that of the standard estradiol group.   
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